Physician Assistant, Medical · Raleigh, NC
NPI
1699081315
Since 2010
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
7780 Brier Creek Pkwy, 200
Raleigh, NC, 27617
Phone (919) 596-3400
Groups this clinician bills Medicare through
Medicare paid, 2024
$110K
1,105 services
Medicare patients, 2024
131
Average age 65
Drug cost, 2024
$970K
6,588 prescriptions
Company payments, 2025
$196
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Omobola D Gold was code 99214 (office e&m - established), 408 times for 114 patients. In total Omobola D Gold billed 1,105 services in 8 codes, and Medicare paid $110K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-12-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 408 | 114 | $49.97 | $20K |
| 80307 Drug Tests | Office | 351 | 110 | $60.90 | $21K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 180 | 59 | $194.77 | $35K |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 102 | 47 | $241.98 | $25K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 42 | 18 | $153.46 | $6,445 |
| 99205 Office E&M - New | Office | 18 | 18 | $111.14 | $2,001 |
By year: 2022 $105K for 1,113 services; 2023 $120K for 1,207 services; 2024 $110K for 1,105 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 351 | 110 | $60.90 | $21K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 180 | 59 | $194.77 | $35K |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 102 | 47 | $241.98 | $25K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 42 | 18 | $153.46 | $6,445 |
Medicare prescription drug claims, 2024
In 2024, the drug Omobola D Gold prescribed most often to Medicare patients was Oxycodone Hcl, with 1,278 prescriptions and refills. In total Omobola D Gold wrote 6,588 Medicare prescriptions that cost $970K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 1,278 | 1,278 | 233 | $23K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 705 | 705 | 143 | $93K |
| Morphine Sulfate Er Morphine Sulfate | 547 | 547 | 86 | $18K |
| Gabapentin Generic | 384 | 442 | 92 | $4,401 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 304 | 304 | 64 | $10K |
| Pregabalin Generic | 291 | 321 | 58 | $4,887 |
| Xtampza Er Oxycodone Myristate | 252 | 252 | 62 | $178K |
| Tizanidine Hcl Generic | 238 | 294 | 57 | $3,410 |
| Oxycontin Oxycodone Hcl | 211 | 211 | 31 | $181K |
| Cyclobenzaprine Hcl Generic | 203 | 246 | 54 | $2,340 |
| Fentanyl Generic | 181 | 181 | 28 | $33K |
| Hydromorphone Hcl Generic | 136 | 136 | 22 | $2,091 |
| Duloxetine Hcl Generic | 126 | 154 | 30 | $1,425 |
| Lidocaine Generic | 114 | 116 | 40 | $14K |
| Methadone Hcl Generic | 99 | 99 | 14 | $2,011 |
Brand drugs: 926 claims; generic drugs: 5,662 claims; opioid claims: 3,999.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Omobola D Gold $196 ($196 in general payments such as food, travel and fees) from 6 companies. The largest payer was Braeburn Inc. with $68.84.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.